Patents by Inventor Thomas Barber

Thomas Barber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260062759
    Abstract: Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of ˜90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention and monitoring.
    Type: Application
    Filed: September 18, 2025
    Publication date: March 5, 2026
    Inventors: Tobias Sjoblom, Sian Jones, D. Williams Parsons, Laura D. Wood, Jimmy Cheng-Ho Lin, Thomas Barber, Diana Mandelker, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu
  • Patent number: 12346431
    Abstract: A tainting engine can work in conjunction with a syntax attack detection template to identify when a threat actor attempts a malicious attack in a cloud application scenario. Non-intrusive instrumentation can be used to provide detection of an attempted attack regardless of whether the cloud application is vulnerable to such attacks. Detection of attempted attacks can be an important part of maintaining network security, even in cases where an application itself is not vulnerable to such attacks. Further details about the attempted attack can be assembled, and a variety of actions can be taken in response to detection.
    Type: Grant
    Filed: February 27, 2023
    Date of Patent: July 1, 2025
    Assignee: SAP SE
    Inventors: Cedric Hebert, Thomas Barber, Suv Sanjit Patnaik
  • Patent number: 12182273
    Abstract: Code injection is a type of security vulnerability in which an attacker injects client-side scripts modifying the content being delivered. A sanitizer function may provide defense against such attacks by removing certain characters (e.g., characters causing state transitions in HTML). A string sanitizer may be modeled in order to determine its effectiveness by obtaining data flow information indicating string operations that used an input string or information derived therefrom, including a string sanitizer function. A deterministic finite automata representing string values of the output parameter may be generated based on a graph generated from the data flow information, where the automata accepts possible output string values of the sanitizer. It can be determined whether there is a non-empty intersection between the automata for the sanitizer output and an automata representing a security exploit, which would indicate that the sanitizer function is vulnerable to the exploit.
    Type: Grant
    Filed: February 4, 2022
    Date of Patent: December 31, 2024
    Assignee: SAP SE
    Inventors: Thomas Barber, David Klein, Martin Johns
  • Publication number: 20240344137
    Abstract: Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of ˜90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention and monitoring.
    Type: Application
    Filed: November 22, 2023
    Publication date: October 17, 2024
    Inventors: Tobias Sjoblom, Sian Jones, D. Williams Parsons, Laura D. Wood, Jimmy Cheng-Ho Lin, Thomas Barber, Diana Mandelker, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculesu
  • Publication number: 20240291858
    Abstract: A tainting engine can work in conjunction with a syntax attack detection template to identify when a threat actor attempts a malicious attack in a cloud application scenario. Non-intrusive instrumentation can be used to provide detection of an attempted attack regardless of whether the cloud application is vulnerable to such attacks. Detection of attempted attacks can be an important part of maintaining network security, even in cases where an application itself is not vulnerable to such attacks. Further details about the attempted attack can be assembled, and a variety of actions can be taken in response to detection.
    Type: Application
    Filed: February 27, 2023
    Publication date: August 29, 2024
    Applicant: SAP SE
    Inventors: Cedric Hebert, Thomas Barber, Suv Sanjit Patnaik
  • Publication number: 20230252159
    Abstract: Code injection is a type of security vulnerability in which an attacker injects client-side scripts modifying the content being delivered. A sanitizer function may provide defense against such attacks by removing certain characters (e.g., characters causing state transitions in HTML). A string sanitizer may be modeled in order to determine its effectiveness by obtaining data flow information indicating string operations that used an input string or information derived therefrom, including a string sanitizer function. A deterministic finite automata representing string values of the output parameter may be generated based on a graph generated from the data flow information, where the automata accepts possible output string values of the sanitizer. It can be determined whether there is a non-empty intersection between the automata for the sanitizer output and an automata representing a security exploit, which would indicate that the sanitizer function is vulnerable to the exploit.
    Type: Application
    Filed: February 4, 2022
    Publication date: August 10, 2023
    Inventors: Thomas Barber, David Klein, Martin Johns
  • Publication number: 20230177166
    Abstract: Embodiments relate to improving accuracy of security vulnerability detection by determining a context of a data flow from a target, generating an exploit, and injecting the exploit based upon the context to create a vulnerable Uniform Resource Locator (URL). The context may comprise a HTML context, a URL context, a JavaScript context, or a JSON context. Communication of the vulnerable URL to a testing platform results in validation of the presence of a security vulnerability. Embodiments may find particular value in detecting vulnerability to a client-side XSS attack, by generating a vulnerable URL containing an exploit that is injected based upon a collected taint flow. Where the target is a website, embodiments improve accuracy of client-side XSS validation exploits by identifying which characters of a URL enter a specific context (e.g., HTML or JavaScript), and replacing these characters with a payload designed to trigger code execution for validation.
    Type: Application
    Filed: December 6, 2021
    Publication date: June 8, 2023
    Inventors: Souphiane Bensalim, Thomas Barber, David Klein, Martin Johns
  • Patent number: 11526600
    Abstract: Various embodiments of systems and methods to track tainting information via non-intrusive bytecode instrumentation are described herein. The described techniques include, at one aspect, defining a taint-aware class to shadow an original data class. The taint-aware class includes a payload field to store objects of the original data class, a metadata field to store tainting information corresponding to the objects of the original data class, and a method proxying a corresponding method of the original data class. In another aspect, the instances of the original data class are replaced with corresponding instances of the taint-aware class in an application bytecode. Further, in a yet another aspect, when executing the application in a runtime environment, the method propagates the content of the metadata filed and calls the corresponding method of the original data class to manage the content of the payload field.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: December 13, 2022
    Assignee: SAP SE
    Inventors: Thomas Barber, David Klein, Martin Johns
  • Publication number: 20220197998
    Abstract: Various embodiments of systems and methods to track tainting information via non-intrusive bytecode instrumentation are described herein. The described techniques include, at one aspect, defining a taint-aware class to shadow an original data class. The taint-aware class includes a payload field to store objects of the original data class, a metadata field to store tainting information corresponding to the objects of the original data class, and a method proxying a corresponding method of the original data class. In another aspect, the instances of the original data class are replaced with corresponding instances of the taint-aware class in an application bytecode. Further, in a yet another aspect, when executing the application in a runtime environment, the method propagates the content of the metadata filed and calls the corresponding method of the original data class to manage the content of the payload field.
    Type: Application
    Filed: December 18, 2020
    Publication date: June 23, 2022
    Inventors: Thomas Barber, David Klein, Martin Johns
  • Patent number: 10787712
    Abstract: Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of ˜90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention and monitoring.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: September 29, 2020
    Assignee: The Johns Hopkins University
    Inventors: Tobias Sjoblom, Sian Jones, D. Williams Parsons, Laura D. Wood, Jimmy Cheng-Ho Lin, Thomas Barber, Diana Mandelker, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu
  • Publication number: 20200239970
    Abstract: Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of ˜90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention and monitoring.
    Type: Application
    Filed: March 19, 2020
    Publication date: July 30, 2020
    Inventors: Tobias SJOBLOM, Sian JONES, D. Williams PARSONS, Laura D. WOOD, Jimmy Cheng-Ho LIN, Thomas BARBER, Diana MANDELKER, Bert VOGELSTEIN, Kenneth W. KINZLER, Victor E. VELCULESCU
  • Publication number: 20200048719
    Abstract: Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of ˜90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention and monitoring.
    Type: Application
    Filed: October 25, 2019
    Publication date: February 13, 2020
    Inventors: Tobias SJOBLOM, Sian JONES, D. Williams PARSONS, Laura D. WOOD, Jimmy Cheng-Ho LIN, Thomas BARBER, Diana MANDELKER, Bert VOGELSTEIN, Kenneth W. KINZLER, Victor E. VELCULESCU
  • Patent number: 10444399
    Abstract: A method for determining resistivity of subsurface formations includes generating an initial model of the formations from multiaxial electromagnetic transimpedance measurements, the model comprising values of vertical resistivity, horizontal resistivity, crossbed dip, crossbed azimuth, and bedding dip and azimuth. Expected measurements generated from the initial model measurements are decomposed into ordinary and extraordinary components. The actual tool measurements are compared to the summation of the expected decomposed measurement components. The initial model is adjusted, the expected decomposed components are recalculated and the foregoing are repeated until the difference between the actual tool measurements and the summation of the expected decomposed components falls below a selected threshold.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: October 15, 2019
    Assignee: SCHLUMBERGER TECHNOLOGY CORPORATION
    Inventors: Gong Li Wang, Thomas Barber, Peter Wu, David F. Allen, Aria Abubakar
  • Publication number: 20170362659
    Abstract: Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of ˜90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention and monitoring.
    Type: Application
    Filed: January 24, 2017
    Publication date: December 21, 2017
    Applicant: The Johns Hopkins University
    Inventors: Tobias SJOBLOM, Sian JONES, D. Williams PARSONS, Laura D. WOOD, Jimmy Cheng-Ho LIN, Thomas BARBER, Diana MANDELKER, Bert VOGELSTEIN, Kenneth W. KINZLER, Victor E. VELCULESCU
  • Patent number: 9551037
    Abstract: Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of ˜90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention and monitoring.
    Type: Grant
    Filed: March 25, 2014
    Date of Patent: January 24, 2017
    Assignee: The Johns Hopkins University
    Inventors: Tobias Sjoblom, Sian Jones, D. Williams Parsons, Laura D. Wood, Jimmy Cheng-Ho Lin, Thomas Barber, Diana Mandelker, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu
  • Patent number: 9174222
    Abstract: The invention features devices and methods for the deterministic separation of particles. Exemplary methods include the enrichment of a sample in a desired particle or the alteration of a desired particle in the device. The devices and methods are advantageously employed to enrich for rare cells, e.g., fetal cells, present in a sample, e.g., maternal blood and rare cell components, e.g., fetal cell nuclei. The invention further provides a method for preferentially lysing cells of interest in a sample, e.g., to extract clinical information from a cellular component, e.g., a nucleus, of the cells of interest. In general, the method employs differential lysis between the cells of interest and other cells (e.g., other nucleated cells) in the sample.
    Type: Grant
    Filed: September 14, 2011
    Date of Patent: November 3, 2015
    Assignees: The General Hospital Corporation, GPB Scientific, LLC
    Inventors: Lotien Richard Huang, Thomas Barber, Bruce L. Carvalho, Ravi Kapur, Paul Vernucci, Mehmet Toner, Zihua Wang
  • Publication number: 20150276966
    Abstract: A method for determining resistivity of subsurface formations includes generating an initial model of the formations from multiaxial electromagnetic transimpedance measurements, the model comprising values of vertical resistivity, horizontal resistivity, crossbed dip, crossbed azimuth, and bedding dip and azimuth. Expected measurements generated from the initial model measurements are decomposed into ordinary and extraordinary components. The actual tool measurements are compared to the summation of the expected decomposed measurement components. The initial model is adjusted, the expected decomposed components are recalculated and the foregoing are repeated until the difference between the actual tool measurements and the summation of the expected decomposed components falls below a selected threshold.
    Type: Application
    Filed: March 26, 2015
    Publication date: October 1, 2015
    Inventors: Gong Li Wang, Thomas Barber, Peter Wu, David F. Allen, Aria Abubakar
  • Patent number: 9061793
    Abstract: A cover for a food holder includes a body having an inner surface and an outer surface, the body having at least one aperture provided therein, the at least one aperture providing communication between the inner surface and the outer surface; and a serving implement having a first portion extending through the aperture along one of the inner and outer surfaces, and a second portion extending along the other of the inner and outer surfaces.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: June 23, 2015
    Assignee: BRADSHAW INTERNATIONAL, INC.
    Inventor: Thomas Barber
  • Publication number: 20150167095
    Abstract: Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of ˜90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention and monitoring.
    Type: Application
    Filed: March 25, 2014
    Publication date: June 18, 2015
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Tobias SJOBLOM, Sian JONES, D. Williams PARSONS, Laura D. WOOD, Jimmy Cheng-Ho LIN, Thomas BARBER, Diana MANDELKER, Bert VOGELSTEIN, Kenneth W. KINZLER, Victor E. VELCULESCU
  • Publication number: 20140377754
    Abstract: Human cancer is caused by the accumulation of mutations in oncogenes and tumor suppressor genes. To catalogue the genetic changes that occur during tumorigenesis, we isolated DNA from 11 breast and 11 colorectal tumors and determined the sequences of the genes in the Reference Sequence database in these samples. Based on analysis of exons representing 20,857 transcripts from 18,191 genes, we conclude that the genomic landscapes of breast and colorectal cancers are composed of a handful of commonly mutated gene “mountains” and a much larger number of gene “hills” that are mutated at low frequency. We describe statistical and bioinformatic tools that may help identify mutations with a role in tumorigenesis. These results have implications for understanding the nature and heterogeneity of human cancers and for using personal genomics for tumor diagnosis and therapy.
    Type: Application
    Filed: August 5, 2014
    Publication date: December 25, 2014
    Inventors: Laura D. WOOD, D. Williams PARSONS, Sian JONES, Jimmy Cheng-Ho LIN, Tobias SJOBLOM, Thomas BARBER, Giovanni PARMIGIANI, Victor VELCULESCU, Kenneth W. KINZLER, Bert VOGELSTEIN